Showing results (351-360 of 377) with videos related to

Sort By:
Pageof 38
Atherosclerosis|February 10, 1997
Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL geneP Knudsen, M Antikainen, M Uusi-Oukari, et al.
European Heart Journal|September 17, 1999
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT)A Kleemann, S Eckert, A von Eckardstein, et al.
The Journal of Biological Chemistry|August 25, 1984
Abnormal lecithin:cholesterol acyltransferase activation by a human apolipoprotein A-I variant in which a single lysine residue is deletedS C Rall, K H Weisgraber, R W Mahley, et al.
The Journal of Clinical Investigation|March 21, 1998
Adenosine(5') oligophospho-(5') guanosines and guanosine(5') oligophospho-(5') guanosines in human plateletsH Schlüter, I Grobeta, J Bachmann, et al.
The Netherlands Journal of Medicine|November 1, 1996
Compound heterozygosity for a known and a novel defect in the lipoprotein lipase gene (Asp250-->Asn; Ser251-->Cys) resulting in lipoprotein lipase (LPL) deficiencyS M Bijvoet, H Wiebusch, Y Ma, et al.
Nature Genetics|August 4, 1999
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1S Rust, M Rosier, H Funke, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 30, 1999
Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol effluxU Daum, C Langer, N Duverger, et al.
Biochemistry|December 7, 2000
Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol effluxJ R Nofer, M Fobker, G Höbbel, et al.
Journal of Lipid Research|June 4, 1998
Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-IA von Eckardstein, A Chirazi, S Schuler-Lüttmann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 2, 1999
c-erbB-2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cellsB H Brandt, A Roetger, T Dittmar, et al.
Pageof 38